Lidocaine Hydrochloride
LIDO CAINE HYDROCHLORIDE INJECTION, USP
Approved
Approval ID
fecd1797-7757-4da8-b3a1-24b258634243
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 12, 2022
Manufacturers
FDA
Asclemed USA, Inc.
DUNS: 059888437
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lidocaine Hydrochloride
PRODUCT DETAILS
NDC Product Code76420-078
Application NumberANDA084625
Marketing CategoryC73584
Route of AdministrationEPIDURAL, INFILTRATION, INTRACAUDAL
Effective DateOctober 12, 2022
Generic NameLidocaine Hydrochloride
INGREDIENTS (4)
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
LIDOCAINE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR
SODIUM CHLORIDEInactive
Quantity: 6 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT